Annual Drug Patent Expirations for MYTESI Mytesi is a drug marketed by Napo Pharms Inc and is included in one NDA. It is available from one supplier. There are two…
The post New patent for Napo Pharms drug MYTESI appeared first on DrugPatentWatch – Mak…
Annual Drug Patent Expirations for BRYHALI Bryhali is a drug marketed by Dow Pharm and is included in one NDA. It is available from one supplier. The generic ingredient in…
The post New patent for Dow Pharm drug BRYHALI appeared first on DrugPatentWatc…
Annual Drug Patent Expirations for VRAYLAR Vraylar is a drug marketed by Allergan Sales Llc and is included in one NDA. It is available from one supplier. There are two…
The post New patent for Allergan Sales drug VRAYLAR appeared first on DrugPatentWa…
Annual Drug Patent Expirations for LENVIMA Lenvima is a drug marketed by Eisai Inc and is included in one NDA. It is available from one supplier. There are three patents…
The post New patent for Eisai Inc drug LENVIMA appeared first on DrugPatentWatch …
Annual Drug Patent Expirations for SAXENDA Saxenda is a drug marketed by Novo and is included in one NDA. It is available from one supplier. There are nineteen patents protecting…
The post New patent for NOVO drug SAXENDA appeared first on DrugPatentWa…
Annual Drug Patent Expirations for GALAFOLD Galafold is a drug marketed by Amicus Theraps Us and is included in one NDA. It is available from one supplier. There are seven…
The post New patent for Amicus Theraps drug GALAFOLD appeared first on DrugPate…
Annual Drug Patent Expirations for VICTOZA Victoza is a drug marketed by Novo Nordisk Inc and is included in one NDA. It is available from one supplier. There are eight…
The post New patent for Novo Nordisk drug VICTOZA appeared first on DrugPatentWatc…
Annual Drug Patent Expirations for XHANCE Xhance is a drug marketed by Optinose Us Inc and is included in one NDA. It is available from one supplier. There are thirteen…
The post New patent for Optinose Us drug XHANCE appeared first on DrugPatentWatch …
Annual Drug Patent Expirations for XULTOPHY+100%2F3.6 Xultophy 100/3.6 is a drug marketed by Novo and is included in one NDA. It is available from one supplier. There are eighteen patents…
The post New patent for NOVO drug XULTOPHY 100/3.6 appeared fir…
Annual Drug Patent Expirations for QBRELIS Qbrelis is a drug marketed by Silvergate Pharms and is included in one NDA. It is available from one supplier. There are four patents…
The post New patent for Silvergate Pharms drug QBRELIS appeared first on D…